Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal
Restricted accessOtherFirst published online April, 2009
Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal
Tumefactive demyelinating lesions are a known but uncommon complication of multiple sclerosis, a disease rarely reported in children. This is the case of a 16-year-old African American patient with multiple sclerosis, who developed 2 tumefactive demyelinating lesions. Review of the literature and our own experience helped formulate an algorithm for therapeutic options during an acute attack.
Selkirk SM, Shi J.Relapsing-remitting tumefactive multiple sclerosis. Mult Scler . 2005;11:731-734.
4.
Zalneraitis EL, Vonsattel J-P.Case 26-1998-A 15-year-old girl with hemiparesis, slurred speech, and an intracranial lesion [Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises] . N Engl J Med.1998;339:542-549.
5.
Kumar K., Toth C., Jay V.Focal plaque of demyelination mimicking cerebral tumor in a pediatric patient . Pediatr Neurosurg. 1998;29:60-63.
6.
Rusin JA, Vezina LG, Chadduck WM, Chandra RSTumoral multiple sclerosis of the cerebellum in a child. Am J Neuroradiol. 1995;16:1164-1166.
7.
Puri V., Chaudhry N., Gulati P., et al. Recurrent tumefactive demyelination in a child. J Clin Neurosci. 2005;12:495-500.
8.
Al-Bunyan MATumor-like presentation of multiple sclerosis . Saudi Med J. 2000;21:393-395.
9.
Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiol. 1992;34:150-154.
10.
Youl BD, Kermode AG, Thompson AJ, et al. Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiat. 1991;54:288-292.
11.
McAdam LC, Blaser SI, Banwell BLPediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol. 2002;26:18-25.
12.
Kepes JJLarge focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol. 1993;33:18-27.
13.
Masdeu JC, Quinto C., Olivera C., et al. Open-ring imaging sign: highly specific for atypical brain demyelination . Neurology. 2000;54:1427-1433.
14.
Cha S., Pierce S., Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. Am J Neuroradiol. 2001 ;22:1109-1116.
15.
Law M., Meltzer DE, Cha S.Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion . Neuroradiology. 2002;44:986-989.
16.
Saindane AM , Cha S., Law M., et al. Proton MR spectroscopy of tumefactive demyelinating lesions. Am J Neuroradiol. 2002 ;23: 1378-1386.
17.
Butteriss DJA , Ismail A., Ellison DW, Birchall D.Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Brit J Radiol. 2003;76:662-665.
18.
Enzinger C. , Strasser-Fuchs S., Ropele S., et al. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging . Mult Scler. 2005;11:135-139.
19.
Metafratzi Z., Argyropoulou MI, Tzoufi M., et al. Conventional MRI and magnetisation transfer imaging of tumour-like multiple sclerosis in a child. Neuroradiology. 2002;44:97-99.
20.
Tsui EYK , Leung WH, Chan JH, et al. Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imag and Graph . 2002;26: 343-346.
21.
Ernst T., Chang L., Walot I., Huff K.Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology. 1998;51: 1486-1488.
22.
Erana-Rojas IE , Barboza-Quintana A., Ayala AG, Fuller GNDemyelinating pseudotumor . Ann Diagn Pathol. 2002;6: 265-271.
23.
Zagzag D., Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol.1993;17:537-545.
24.
Sugita Y., Terasaki M., Shigemori M., et al. Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis. Neuropathology. 2001;21:25-31.
25.
Ness JM, Chabas D., Sadovnick AD, et al. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007;68(suppl) 2:S37-S45.
26.
Mao-Draayer Y. , Braff S., Pendlebury W., Panitch H.Treatement of steroid-unresponsive tumefactive demyelinating disease with plasma exchange . Neurology. 2002;59:1074-1077.
27.
Waldman A., O'Connor E., Tennekoon G.Childhood multiple sclerosis: a review. Ment Retard Dev Disabil Res Rev. 2006;12: 147-156.
28.
Soelberg Sorensen P., Haas J., Sellebjerg F., et al. IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS. Neurology . 2004;63:2028-2033.
29.
Pohl D., Waubant E., Banwell B., et al. Treatment of pediatric multiple sclerosis and variants. Neurology. 2007;68(suppl 2): S54-S65.
30.
Takahashi I. , Sawaishi Y., Takeda O., et al. Childhood multiple sclerosis treated with plasmapheresis. Pediatr Neurol. 1997;17:83-87.
31.
Pohl D., Rostasy K., Gartner J., Hanefeld F.Treatement of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology. 2005;64:888-890.
32.
Tenembaum SN , Segura MJInterferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology . 2006;67:511-513.
33.
Mikaeloff Y. , Moreau T., Debouverie M., et al. Interferon-ß treatment in patients with childhood-onset multiple sclerosis. J Pediatr. 2001;139:443-446.
34.
Malucchi S. , Sala A., Gilli F., et al. Neutralizing antibodies reduce the efficacy of ßIFN during treatment of multiple sclerosis. Neurology. 2004;62:2031-2037.
35.
Jeffery DRThe argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis. J Neurol Sci. 2004;223:41-46.
36.
Gauthier SA , Weiner HLCyclophosphamide therapy for MS . Int Mult Scler J. 2005;12:52-58.
37.
Patti F., Reggio E., Palermo F., et al. Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with IFN beta plus cyclophosphamide followed by interferon beta. J Neurol. 2004;251:1502-1506.
38.
Yapici Z., Eraksoy M.Bilateral demyelinating tumefactive lesions in three children with hemiparesis . J Child Neurol. 2002;17: 655-660.
39.
Harpey JP, Renault F., Foncin JF, et al. Démyélinisation aiguë pseudotumorale a poussees regressives . Arch Fr Pediatr. 1983;40:407-409.
40.
Banwell B., Shroff M., Ness JM, et al. MRI features of pediatric multiple sclerosis. Neurology. 2007;68(suppl 2):S46-S53.
